0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Endocrine And Metabolic Disorders Drugs Market Research Reports

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
Zoledronic Acid Market Report 2025 - Product Thumbnail Image

Zoledronic Acid Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
EUR$4,490USDGBP
Fabry Disease Market Report 2025 - Product Thumbnail Image

Fabry Disease Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
EUR$4,490USDGBP
From
EUR$4,490USDGBP
Endocrinology Drugs Market Report 2025 - Product Thumbnail Image

Endocrinology Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
EUR$4,490USDGBP
Testosterone Booster Market Report 2025 - Product Thumbnail Image

Testosterone Booster Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
EUR$4,490USDGBP
Denosumab Market Report 2025 - Product Thumbnail Image

Denosumab Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
EUR$4,490USDGBP
Alpha Mannosidosis Market Report 2025 - Product Thumbnail Image

Alpha Mannosidosis Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
EUR$4,490USDGBP
Peptide Based Metabolic Disorders Therapeutics Market Report 2025 - Product Thumbnail Image

Peptide Based Metabolic Disorders Therapeutics Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
EUR$4,490USDGBP
Hyperphosphatemia Treatment Market Report 2025 - Product Thumbnail Image

Hyperphosphatemia Treatment Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
EUR$4,490USDGBP
Hormone Therapy Market Report 2025 - Product Thumbnail Image

Hormone Therapy Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
EUR$4,490USDGBP
Testosterone Replacement Therapy Market Report 2025 - Product Thumbnail Image

Testosterone Replacement Therapy Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
EUR$4,490USDGBP
Lactose Intolerance Treatment Market Report 2025 - Product Thumbnail Image

Lactose Intolerance Treatment Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
EUR$4,490USDGBP
Male Hypogonadism Market Report 2025 - Product Thumbnail Image

Male Hypogonadism Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
EUR$4,490USDGBP
Lysosomal Disease Treatment Market Report 2025 - Product Thumbnail Image

Lysosomal Disease Treatment Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
EUR$4,490USDGBP
Insulin biosimilars Market Report 2025 - Product Thumbnail Image

Insulin biosimilars Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
EUR$4,490USDGBP
Osteoporosis Drugs Market Report 2025 - Product Thumbnail Image

Osteoporosis Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
EUR$4,490USDGBP
Angiotensin Receptor Blockers (ARBs) Market Report 2025 - Product Thumbnail Image

Angiotensin Receptor Blockers (ARBs) Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
EUR$4,490USDGBP
Glucagon-like Peptide 1 Global Market Report 2025 - Product Thumbnail Image

Glucagon-like Peptide 1 Global Market Report 2025

  • Report
  • July 2025
  • 250 Pages
  • Global
From
EUR$4,490USDGBP
Meibomian Gland Dysfunction Global Market Report 2025 - Product Thumbnail Image

Meibomian Gland Dysfunction Global Market Report 2025

  • Report
  • July 2025
  • 175 Pages
  • Global
From
EUR$4,490USDGBP
Hypoprothrombinemia Treatment Global Market Report 2025 - Product Thumbnail Image

Hypoprothrombinemia Treatment Global Market Report 2025

  • Report
  • July 2025
  • 175 Pages
  • Global
From
EUR$4,490USDGBP
Loading Indicator

The Endocrine and Metabolic Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and production of drugs used to treat endocrine and metabolic disorders. Endocrine disorders are conditions that affect the body's hormones, while metabolic disorders are conditions that affect the body's ability to process and use energy. Endocrine and metabolic disorders can include diabetes, thyroid disorders, obesity, and adrenal disorders. Endocrine and Metabolic Disorders Drugs are typically developed by pharmaceutical companies and are prescribed by physicians. These drugs can be used to treat a variety of endocrine and metabolic disorders, including diabetes, thyroid disorders, obesity, and adrenal disorders. Common drugs used to treat these conditions include insulin, metformin, and glucagon-like peptide-1 (GLP-1) agonists. Some of the major companies in the Endocrine and Metabolic Disorders Drugs market include Novo Nordisk, Sanofi, Eli Lilly, Merck, and AstraZeneca. These companies are involved in the development, production, and marketing of drugs used to treat endocrine and metabolic disorders. Show Less Read more